• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 7, Issue 11
  3. Author

Online ISSN: 2515-8260

Volume7, Issue11

Optimized Residual Convolutional Learning Neural Network for Intrapartum Maternal-Embryo Risk Assessment

    K. Parvathavarthine, Dr. R. Balasubramanian

European Journal of Molecular & Clinical Medicine, 2020, Volume 7, Issue 11, Pages 2985-3006

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

An effective fetal electrocardiogram (FECG) and ultrasound sonography (USG) signals with continues watching is a testing tool utilized by obstetricians to assess the maternal and embryo stage classification method are proposed utilizing a deep 2D convolutional neural network (CNN) which nowadays observe excellent presentation in the field of design identification. Because of the convolution and irregularity, a visible explanation of both Fetal Heart Rate or FHR and Uterine Contractions or UC signals utilizing usual instructions commonly obtained in remarkable individual inter-observer and intra-observer changeability. As a result, automated system depends on modern artificial intelligence (AI) innovation has nowadays been evolved to assist obstetricians in manufacturing targeted medical conclusions. The major object of this research was to make sure a novel, steady, strong, and effective model for maternal and embryo risk detection. Moreover, multiple CNNs is optimized through Genetic Algorithm (GA), overcomes the majority decision drawback in the traditional voting method. Improvement of the suggested classifier incorporate different deep studying methods such as transfer learning, GA initialization, multiple convolutional layers, hybrid optimization SGD with Adam and dropout with softmax were used in the experiments. And then, we differentiated our CNN classifier with four familiar CNN optimized models; such as SGD, Rmsprop, Adam and Adagrad. Depends  on the experiment freely available database (CTU-UHB), we got good categorization presentation, after complete investigation, utilizing the proposed Optimized Residual Convolutional Learning Neural Network  method with average cross-validation (10 fold) of the Acc, TPR, TNR, PPV, NPV, HM, Kappa, AUC, PRAUC, Log Loss, DR, Prevalence, DP and BA respectively. Once the proposed Optimized Residual Convolutional Learning Neural Network model with 10 layers is achieved 96.24 % accuracy in average with successfully trained with the 8 different risk factors, the corresponding automated system can be used as a potent device to detect maternal and embryo risk state objectively and accurately.
Keywords:
  • PDF (1178 K)
  • XML
(2021). Optimized Residual Convolutional Learning Neural Network for Intrapartum Maternal-Embryo Risk Assessment. European Journal of Molecular & Clinical Medicine, 7(11), 2985-3006.
K. Parvathavarthine, Dr. R. Balasubramanian. "Optimized Residual Convolutional Learning Neural Network for Intrapartum Maternal-Embryo Risk Assessment". European Journal of Molecular & Clinical Medicine, 7, 11, 2021, 2985-3006.
(2021). 'Optimized Residual Convolutional Learning Neural Network for Intrapartum Maternal-Embryo Risk Assessment', European Journal of Molecular & Clinical Medicine, 7(11), pp. 2985-3006.
Optimized Residual Convolutional Learning Neural Network for Intrapartum Maternal-Embryo Risk Assessment. European Journal of Molecular & Clinical Medicine, 2021; 7(11): 2985-3006.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 203
  • PDF Download: 414
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus